Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

NCT: NCT05554172 · RECRUITING

NCT IDNCT05554172
StatusRECRUITING
Start Date2022-12-13
Completion2027-10
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

Brief Summary

This project includes a 4-week randomized trial comparing pre-meal vagal nerve stimulation (taVNS) to pre-meal sham stimulation. The aims will assess if taVNS results in greater satisfaction, greater calorie consumption, less self-reported fullness, decrease in eating disorder symptoms, and less anxiety than sham stimulation.

Frequently Asked Questions

What is Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders?

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders is a clinical trial registered under NCT05554172. Current status: RECRUITING.

What is the status of NCT05554172?

The current status of NCT05554172 (Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders) is: RECRUITING.

When did Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders start?

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders started on 2022-12-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑